Veeva Systems (NYSE:VEEV) Updates FY 2027 Earnings Guidance

Veeva Systems (NYSE:VEEV) issued an update on its FY 2027 earnings guidance on Wednesday. The company provided EPS guidance of 9.210-9.210 for the period, compared to the consensus earnings per share estimate of 8.580. The company issued revenue guidance of $3.7 billion-$3.7 billion, compared to the consensus revenue estimate of $3.6 billion. Veeva Systems also updated its Q3 2027 guidance to 2.330-2.340 EPS.

Analyst Ratings Changes

A number of equities analysts have recently commented on VEEV shares. Piper Sandler started coverage on Veeva Systems in a report on Monday. They issued an “overweight” rating and a $295.00 target price for the company. Oppenheimer upped their target price on Veeva Systems from $225.00 to $300.00 and gave the company an “outperform” rating in a research report on Monday, August 17th. Wells Fargo & Company increased their price target on shares of Veeva Systems from $317.00 to $320.00 and gave the stock an “overweight” rating in a report on Thursday, June 4th. Royal Bank Of Canada reissued an “outperform” rating and set a $275.00 price target on shares of Veeva Systems in a report on Thursday, June 4th. Finally, Stifel Nicolaus increased their target price on Veeva Systems from $230.00 to $275.00 and gave the company a “buy” rating in a report on Monday, August 17th. Nineteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $256.62.

Veeva Systems Stock Down 0.8%

Shares of NYSE:VEEV opened at $244.72 on Thursday. Veeva Systems has a fifty-two week low of $148.05 and a fifty-two week high of $310.50. The company has a market cap of $39.75 billion, a price-to-earnings ratio of 43.62, a PEG ratio of 1.06 and a beta of 0.92. The firm’s 50-day simple moving average is $203.41 and its 200-day simple moving average is $183.04.

Veeva Systems (NYSE:VEEV) last posted its earnings results on Wednesday, August 26th. The technology company reported $2.35 earnings per share for the quarter, beating the consensus estimate of $2.22 by $0.13. Veeva Systems had a return on equity of 13.72% and a net margin of 28.37%.The company had revenue of $927.96 million for the quarter, compared to analyst estimates of $905.38 million. During the same quarter in the prior year, the company earned $1.99 earnings per share. Veeva Systems’s revenue was up 17.6% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. On average, research analysts forecast that Veeva Systems will post 6.65 EPS for the current year.

Insider Buying and Selling

In other Veeva Systems news, insider Thomas D. Schwenger sold 36,000 shares of the company’s stock in a transaction that occurred on Thursday, August 13th. The stock was sold at an average price of $250.23, for a total value of $9,008,280.00. Following the transaction, the insider directly owned 19,449 shares of the company’s stock, valued at $4,866,723.27. This represents a 64.92% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is owned by corporate insiders.

Key Stories Impacting Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Quarterly results exceeded expectations. Veeva reported fiscal Q2 revenue of $928.0 million, up 17.6% year over year, including subscription revenue of $766.8 million, up 16%. Earnings of $2.35 per share surpassed the $2.22 consensus estimate. Veeva Announces Fiscal 2027 Second Quarter Results
• Positive Sentiment: Forward guidance was materially above Wall Street forecasts. Veeva guided fiscal Q3 revenue to $932 million-$935 million and EPS to $2.33-$2.34, compared with consensus estimates of $917.9 million and $2.16, respectively. Fiscal 2027 revenue guidance was approximately $3.7 billion and EPS guidance was $9.21, both above analyst expectations.
• Positive Sentiment: AI and CRM momentum supported the outlook. Management expects the first customers to go live with Falcon, its next-generation AI offering, this year, while targeting retention of more than 70% share of the life sciences CRM market. Management also highlighted AI-driven demand and continued adoption of its Vault platform. Veeva CRM and Falcon Update
• Positive Sentiment: Major customer wins strengthened the competitive case. Regeneron and Biogen committed to Veeva Vault CRM globally, providing evidence that Veeva is maintaining its market leadership and expanding adoption among large biopharmaceutical companies. Veeva Vault CRM Selected by Regeneron
• Neutral Sentiment: Needham reaffirmed a Buy rating, while Piper Sandler initiated coverage. These analyst actions add support but are less significant than the earnings and guidance updates. Needham Reaffirms Buy Rating
• Neutral Sentiment: Veeva’s 28.37% net margin, strong balance-sheet profile, and recurring subscription model remain attractive, although the stock’s elevated valuation—with a reported P/E ratio above 43—leaves less room for execution disappointments.

Hedge Funds Weigh In On Veeva Systems

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Williams Jones Wealth Management LLC. lifted its position in Veeva Systems by 0.4% during the 3rd quarter. Williams Jones Wealth Management LLC. now owns 9,419 shares of the technology company’s stock worth $2,806,000 after acquiring an additional 40 shares during the period. Rafferty Asset Management LLC increased its holdings in shares of Veeva Systems by 0.7% in the second quarter. Rafferty Asset Management LLC now owns 6,881 shares of the technology company’s stock valued at $1,982,000 after purchasing an additional 51 shares during the period. Brown Brothers Harriman & Co. raised its stake in shares of Veeva Systems by 8.1% during the third quarter. Brown Brothers Harriman & Co. now owns 719 shares of the technology company’s stock worth $214,000 after purchasing an additional 54 shares during the last quarter. Raiffeisen Bank International AG lifted its holdings in shares of Veeva Systems by 59.8% during the fourth quarter. Raiffeisen Bank International AG now owns 155 shares of the technology company’s stock worth $35,000 after purchasing an additional 58 shares during the period. Finally, Rakuten Securities Inc. grew its position in Veeva Systems by 56.7% in the 2nd quarter. Rakuten Securities Inc. now owns 163 shares of the technology company’s stock valued at $47,000 after buying an additional 59 shares during the last quarter. Institutional investors own 88.20% of the company’s stock.

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.